New genetic test for childhood cancer

New genetic test for childhood cancer, 81 different genetic tests for childhood cancers. Genetic testing for childhood cancers in India. Cost of genetic testing in childhood cancers.

Share This Post

British scientists begin genetic testing of childhood tumors. British scientists hope that genetic testing will give younger patients newer and more personalized treatments that will increase their survival. The new test analyzes 81 different cancer genetic changes.
Scientists say the test will lead “a higher level of playing field” and accelerate children’s access to important new drug treatments. The test was performed at the Royal Marsden National Health System Hospital in London and will be tested on 400 children from all over the UK over the next two years.
The test has been implemented with genetic funding from the National Institutes of Health (NIHR) foundation and the Cancer Institute.
A charity called Christopher has provided more than £ 300,000 in funding to develop the test. The organization was founded by a couple whose children died of invasive brain tumors at the age of six.
“This is a real first step towards personalized cancer treatment for children,” said Christopher’s parents Karen and Kevin Capel.

“Christopher got a generic tumor. Hopefully, in the future, children will know exactly what type of tumor they have.”
“We almost feel that the treatment for the child is not to kill the cancer, but to kill our child.”
“He used to be a healthy, happy, very athletic 4-year-old kid. But he became unable to speak or even eat on his own, and lost weight.
“In the year he was diagnosed, he was unable to grow into a child of his age. We tried to keep him from other children.”
Malignant tumors are very rare in children, there are not many patient populations, and clinical trials for pharmaceutical companies will lack motivation. This means that children will miss the opportunity to receive targeted treatments for cancer cells without damaging healthy cells with innovative therapies.
Professor Louis Chesler, who is leading the genetic testing research, said: “Children often don’t have equal access to the most advanced and potentially beneficial cancer treatments.” “The cost of developing gene-targeted drugs is very high. They tend to Test it on adults first so that more people can get treatment and the results can be seen faster. “
“This test is an incredible advance because it will very clearly identify all genetic changes in the tumor.” “Gene testing gives clinicians an extremely powerful tool—helping them choose the right medicine for their children and do their best. It may be possible to quickly determine the effectiveness of these drugs. “
“Children’s tumors are usually genetically simpler than adult tumors, so eventually these drugs may be more effective in children.” The goal of genetic testing is to give scientists and doctors detailed genes for childhood tumors within a few weeks of diagnosis. information.
Genetic testing gives doctors strong evidence to use targeted therapies for younger patients, potentially preventing these patients from the side effects associated with traditional chemotherapy and radiation therapy.

Jack Daly, 14, from Wokingham, was diagnosed with a brain tumor when he was 7 and is now a brain tumor survivor. Radiotherapy helped save his life, but left him with sequelae.
“My athletic ability is not very good,” Jack said. “I have to get someone to help me dress and undress at school.”
“My balance is not good-I am awkward and often fall. I worked hard at school, where I found friendship.”
Jack and his mother, Helen, use their donations to make ends meet in Capels-hoping that genetic testing will make a huge difference in the quality of life of future children.
“People don’t really see the problem because Jack has recovered from cancer. He doesn’t need to be in a wheelchair. He doesn’t have to wear a bandage,” Helen said.
“If you’ve ever seen Jack, he looks like a normal teenage boy. But what you don’t see is the brain tissue damage caused by the treatment.”
Source URL of this article:

For details please write to


Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Ivosidenib is approved by FDA for myelodysplastic syndromes

Ivosidenib is approved by FDA for myelodysplastic syndromes

The Food and Drug Administration approved ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) for adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation, as detected by an FDA-approved test.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

درمان سرطان در تركيه
Start chat
Need help with cancer treatment?
Scan the code
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy